Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28


C1q restrains autoimmunity and viral infection by regulating CD8+ T cell metabolism.

Ling GS, Crawford G, Buang N, Bartok I, Tian K, Thielens NM, Bally I, Harker JA, Ashton-Rickardt PG, Rutschmann S, Strid J, Botto M.

Science. 2018 May 4;360(6388):558-563. doi: 10.1126/science.aao4555.


C1q and Mannose-Binding Lectin Interact with CR1 in the Same Region on CCP24-25 Modules.

Jacquet M, Cioci G, Fouet G, Bally I, Thielens NM, Gaboriaud C, Rossi V.

Front Immunol. 2018 Mar 7;9:453. doi: 10.3389/fimmu.2018.00453. eCollection 2018.


Genetic Map of Mango: A Tool for Mango Breeding.

Kuhn DN, Bally ISE, Dillon NL, Innes D, Groh AM, Rahaman J, Ophir R, Cohen Y, Sherman A.

Front Plant Sci. 2017 Apr 20;8:577. doi: 10.3389/fpls.2017.00577. eCollection 2017.


Structural and Functional Characterization of a Single-Chain Form of the Recognition Domain of Complement Protein C1q.

Moreau C, Bally I, Chouquet A, Bottazzi B, Ghebrehiwet B, Gaboriaud C, Thielens N.

Front Immunol. 2016 Mar 2;7:79. doi: 10.3389/fimmu.2016.00079. eCollection 2016.


Deciphering the fine details of c1 assembly and activation mechanisms: "mission impossible"?

Gaboriaud C, Ling WL, Thielens NM, Bally I, Rossi V.

Front Immunol. 2014 Nov 6;5:565. doi: 10.3389/fimmu.2014.00565. eCollection 2014. Review.


Classical complement pathway components C1r and C1s: purification from human serum and in recombinant form and functional characterization.

Rossi V, Bally I, Lacroix M, Arlaud GJ, Thielens NM.

Methods Mol Biol. 2014;1100:43-60. doi: 10.1007/978-1-62703-724-2_4.


Expression of recombinant human complement C1q allows identification of the C1r/C1s-binding sites.

Bally I, Ancelet S, Moriscot C, Gonnet F, Mantovani A, Daniel R, Schoehn G, Arlaud GJ, Thielens NM.

Proc Natl Acad Sci U S A. 2013 May 21;110(21):8650-5. doi: 10.1073/pnas.1304894110. Epub 2013 May 6.


Structure and properties of the Ca(2+)-binding CUB domain, a widespread ligand-recognition unit involved in major biological functions.

Gaboriaud C, Gregory-Pauron L, Teillet F, Thielens NM, Bally I, Arlaud GJ.

Biochem J. 2011 Oct 15;439(2):185-93. doi: 10.1042/BJ20111027. Review.


Proteins of the innate immune system crystallize on carbon nanotubes but are not activated.

Ling WL, Biro A, Bally I, Tacnet P, Deniaud A, Doris E, Frachet P, Schoehn G, Pebay-Peyroula E, Arlaud GJ.

ACS Nano. 2011 Feb 22;5(2):730-7. doi: 10.1021/nn102400w. Epub 2011 Jan 7.


Mapping surface accessibility of the C1r/C1s tetramer by chemical modification and mass spectrometry provides new insights into assembly of the human C1 complex.

Brier S, Pflieger D, Le Mignon M, Bally I, Gaboriaud C, Arlaud GJ, Daniel R.

J Biol Chem. 2010 Oct 15;285(42):32251-63. doi: 10.1074/jbc.M110.149112. Epub 2010 Jun 30.


Functional characterization of the recombinant human C1 inhibitor serpin domain: insights into heparin binding.

Rossi V, Bally I, Ancelet S, Xu Y, Frémeaux-Bacchi V, Vivès RR, Sadir R, Thielens N, Arlaud GJ.

J Immunol. 2010 May 1;184(9):4982-9. doi: 10.4049/jimmunol.0902016. Epub 2010 Mar 29.


Identification of the C1q-binding Sites of Human C1r and C1s: a refined three-dimensional model of the C1 complex of complement.

Bally I, Rossi V, Lunardi T, Thielens NM, Gaboriaud C, Arlaud GJ.

J Biol Chem. 2009 Jul 17;284(29):19340-8. doi: 10.1074/jbc.M109.004473. Epub 2009 May 27.


Functional role of the linker between the complement control protein modules of complement protease C1s.

Bally I, Rossi V, Thielens NM, Gaboriaud C, Arlaud GJ.

J Immunol. 2005 Oct 1;175(7):4536-42.


Unusual Ca(2+)-calmodulin binding interactions of the microtubule-associated protein F-STOP.

Bouvier D, Vanhaverbeke C, Simorre JP, Arlaud GJ, Bally I, Forge V, Margolis RL, Gans P, Kleman JP.

Biochemistry. 2003 Oct 7;42(39):11484-93.


Substrate specificities of recombinant mannan-binding lectin-associated serine proteases-1 and -2.

Rossi V, Cseh S, Bally I, Thielens NM, Jensenius JC, Arlaud GJ.

J Biol Chem. 2001 Nov 2;276(44):40880-7. Epub 2001 Aug 29.


Crystal structure of the catalytic domain of human complement c1s: a serine protease with a handle.

Gaboriaud C, Rossi V, Bally I, Arlaud GJ, Fontecilla-Camps JC.

EMBO J. 2000 Apr 17;19(8):1755-65.


In vitro analysis of complement-dependent HIV-1 cell infection using a model system.

Tacnet-Delorme P, Boyer V, Thielens NM, Hernandez JF, Bally I, Sim RB, Desgranges C, Arlaud GJ.

J Immunol. 1999 Apr 1;162(7):4088-93.


NMR structures of the C-terminal end of human complement serine protease C1s.

Gans P, Rossi V, Gaboriaud C, Bally I, Hernandez JF, Blackledge MJ, Arlaud GJ.

Cell Mol Life Sci. 1998 Feb;54(2):171-8.


NMR structures of a mitochondrial transit peptide from the green alga Chlamydomonas reinhardtii.

Lancelin JM, Gans P, Bouchayer E, Bally I, Arlaud GJ, Jacquot JP.

FEBS Lett. 1996 Aug 5;391(1-2):203-8.


NMR structures of ferredoxin chloroplastic transit peptide from Chlamydomonas reinhardtii promoted by trifluoroethanol in aqueous solution.

Lancelin JM, Bally I, Arlaud GJ, Blackledge M, Gans P, Stein M, Jacquot JP.

FEBS Lett. 1994 May 2;343(3):261-6.


Further characterization of the interaction between the C1q subcomponent of human C1 and the transmembrane envelope glycoprotein gp41 of HIV-1.

Thielens NM, Bally IM, Ebenbichler CF, Dierich MP, Arlaud GJ.

J Immunol. 1993 Dec 1;151(11):6583-92.


Interaction of C1 with HIV-1.

Thielens NM, Bally IM, Ebenbichler CF, Dierich MP, Arlaud GJ.

Behring Inst Mitt. 1993 Dec;(93):165-70.


Supplemental Content

Support Center